Neurogenesis Antibodies

Ace Therapeutics is dedicated to providing our clients with top-quality antibodies that are associated with stroke neurogenesis. With the expertise of our experienced scientists and cutting-edge technology, we ensure the production of high-quality antibodies that meet the rigorous standards of research and clinical requirements.

Neurogenesis refers to the process of generation, maturation, and connection of nerve cells in the nervous system. During neurogenesis, neural stem cells differentiate into neural precursor cells and then further differentiate into neurons, glial cells, and ganglion cells. This process requires complex steps such as cell migration, formation of synapses, and emergence of dendrites. Neurogenesis plays a role in the restoration and healing of the brain after injury. Following conditions like stroke or trauma, the brain initiates neurogenesis to replace injured neurons and regain normal brain function. Nevertheless, the effectiveness of this repair mechanism relies on the severity and location of the injury. Neural stem cells are responsible for maintaining the neurogenic process, and in the adult brain, they mainly exist in specific areas like the dentate gyrus of the hippocampus and the subgranular zone of the SVZ. Currently, there is a growing body of research exploring enhanced neurogenesis as a potential therapeutic approach to treat stroke.

Ace Therapeutics offers a comprehensive catalog of products for studying stroke neurogenesis, including, but not limited to, vimentin antibodies, LAMP1 antibodies, beta-catenin antibodies, SOX2 antibodies, and Ki67 antibodies.

Please access our all-series neurogenesis antibodies or contact our scientist for personalized assistance.